Literature DB >> 17664116

Statins: an essential component in the management of carotid artery disease.

Kosmas I Paraskevas1, George Hamilton, Dimitri P Mikhailidis.   

Abstract

OBJECTIVE: We aimed to define the role of treatment using statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) in the management of patients with carotid artery disease. LITERATURE SEARCH
METHODS: We searched PubMed for studies evaluating the effect of statins on carotid IMT and the occurrence of cerebrovascular events. LITERATURE SEARCH
RESULTS: Current evidence indicates that routine statin therapy reduces carotid intima-media thickness progression and stroke risk. Additionally, statin treatment significantly reduces perioperative as well as long-term morbidity and mortality in patients undergoing carotid surgery or endovascular interventions. It would also be expected that statins would reduce coronary events in this high-risk population.
CONCLUSIONS: Statins should be considered as an essential component of the therapeutic approach of patients with carotid artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664116     DOI: 10.1016/j.jvs.2007.03.035

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

Review 1.  Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.

Authors:  Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2007-12-08       Impact factor: 2.370

2.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.

Authors:  T Vikan; S H Johnsen; H Schirmer; I Njølstad; J Svartberg
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

Review 3.  2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.

Authors:  Massimo Volpe; Roberto Volpe; Giovanna Gallo; Vivianne Presta; Giuliano Tocci; Emanuela Folco; Andrea Peracino; Elena Tremoli; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-18

4.  An update on the incidence of perioperative outcomes after carotid endarterectomy, stratified by type of preprocedural neurologic symptom.

Authors:  Alexander B Pothof; Emma S Zwanenburg; Sarah E Deery; Thomas F X O'Donnell; Gert J de Borst; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-10-23       Impact factor: 4.268

5.  The Association between Carotid Atherosclerosis and Glucose.

Authors:  Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

Review 6.  Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?

Authors:  Pavel Poredos; Mateja Kaja Jezovnik
Journal:  Int J Mol Sci       Date:  2015-06-25       Impact factor: 5.923

Review 7.  HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.

Authors:  Balasoobramanien Pillay; Pratistadevi K Ramdial; Datshana P Naidoo
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

8.  Risk Factors for Silent Lacunar Infarction in Patients with Transient Ischemic Attack.

Authors:  Ying Li; Nan Liu; Yonghua Huang; Wei Wei; Fei Chen; Weiwei Zhang
Journal:  Med Sci Monit       Date:  2016-02-11

9.  Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers.

Authors:  Michael Koutouzis; Kosmas I Paraskevas; Loukianos S Rallidis; Calypso Barbatis; Alexandros Nomikos; Vasiliki Tzavara; Maria Tsopanomichalou; Christos Lioupis; Nikolaos Bessias; Vassilios Andikopoulos; Dimitri P Mikhailidis; Zenon S Kyriakides
Journal:  Open Cardiovasc Med J       Date:  2008-11-28

10.  Simplified ultrasound protocol for the exclusion of clinically significant carotid artery stenosis.

Authors:  Dominika Högberg; Demosthenes Dellagrammaticas; Björn Kragsterman; Martin Björck; Anders Wanhainen
Journal:  Ups J Med Sci       Date:  2016-07-05       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.